Mustafa Çelik

Mustafa Çelik

Magnero Content Team
...
Views
Read Time
Prostate Cancer: Amazing Guide To Scary Sites
Prostate Cancer: Amazing Guide To Scary Sites 4

Prostate cancer is a big health issue worldwide. Knowing where it starts is key for finding and treating it. Almost 70–80% of prostate cancers begin in one part of the prostate gland.

Studies show that most prostate cancers start in the peripheral zone of the prostate gland. This info helps doctors create better treatment plans. At Liv Hospital, doctors are leading the way in helping patients all over the world.

Key Takeaways

  • Most prostate cancers originate in the peripheral zone of the prostate gland.
  • Understanding the origin of prostate cancer is vital for effective diagnosis and treatment.
  • Targeted treatment strategies are being developed based on the knowledge of where prostate cancer starts.
  • Global expertise, including from leaders like Liv Hospital, is improving outcomes for prostate cancer patients.
  • Prostate cancer is a significant health concern that requires complete care and support.

The Anatomy and Function of the Prostate Gland

To understand prostate cancer, we must first learn about the prostate gland. It’s a complex organ that’s key to male reproductive health.

Structure and Zones of the Prostate

The prostate gland is not one solid part; it’s divided into several zones. These zones are the peripheral, transition, and central zones. Knowing these zones is important because prostate cancer often starts in specific areas.

The peripheral zone is the biggest part and where most prostate cancers start. The transition zone is around the urethra and is where BPH often happens. The central zone is smaller but can also have cancer.

Zone

Characteristics

Cancer Frequency

Peripheral Zone

Largest part of the gland, surrounding the distal urethra

70-80% of prostate cancers

Transition Zone

Surrounds the proximal urethra, common site for BPH

10-20% of prostate cancers

Central Zone

Surrounds the ejaculatory ducts, less common for cancer

Rare cases of prostate cancer

The Role of the Prostate in Male Reproductive Health

The prostate gland is vital for male fertility. It makes a lot of the fluid in semen, which helps and protects sperm. This fluid is full of enzymes, zinc, and other things that help sperm stay healthy.

When a man ejaculates, the prostate gland helps release its fluid into the urethra. This mixes with sperm and other fluids to make semen. This is important for sperm to survive and move well.

Production of Prostatic Fluid

The prostate gland makes prostatic fluid, which is alkaline. This helps sperm survive and move better in the vaginal tract. The fluid also has enzymes and proteins that help semen liquefy after ejaculation, making it easier for sperm to move.

Knowing how the prostate gland works and what it does is key. It helps us understand how problems with it can lead to prostate issues, including cancer.

Understanding Prostate Cancer Development

Prostate Cancer: Amazing Guide To Scary Sites
Prostate Cancer: Amazing Guide To Scary Sites 5

Prostate cancer starts with changes in cells, often in the glandular cells of the prostate. The majority of prostate cancers are adenocarcinomas, which come from these glandular cells. Knowing how prostate cancer develops is key for early detection and treatment.

Cellular Origins of Prostate Cancer

The prostate gland has different cell types, but glandular cells are the most common source of prostate cancer. These cells make prostatic fluid, part of semen. DNA changes in these cells can cause cancer.

Adenocarcinomas from Glandular Cells

More than 99% of prostate cancers are adenocarcinomas, from glandular cells. The Gleason score grades cancer aggressiveness based on microscopic look. A higher score means a more aggressive cancer.

Genetic and Molecular Basis of Prostate Tumors

Prostate cancer development involves complex genetic and molecular changes. Mutations in genes related to cell growth and division can cause cancer. Knowing these genetic changes helps in creating targeted therapies and improving treatment results.

We understand that prostate cancer development is complex, involving genetics, molecules, and environment. By knowing the cellular and genetic roots of prostate cancer, we can improve diagnosis, treatment, and prevention.

The Peripheral Zone: Primary Site of Prostate Cancer

Prostate Cancer: Amazing Guide To Scary Sites
Prostate Cancer: Amazing Guide To Scary Sites 6

Prostate cancer mostly starts in the peripheral zone, which is key for men’s health. This area is where about 70-80% of prostate cancers occur.

Why 70-80% of Prostate Cancers Start Here

The peripheral zone is more likely to get cancer because it’s bigger than other parts of the prostate. Its cells are also more likely to change in ways that lead to cancer.

Studies show that the peripheral zone’s special setup and cells make it more prone to cancer. The high amount of glandular tissue in this area might help explain why prostate cancer often starts here.

Characteristics of Peripheral Zone Tumors

Tumors in the peripheral zone are often more aggressive. They are also more likely to be found late if not caught early.

The table below highlights some key traits of tumors in the peripheral zone:

Characteristic

Description

Location

Mostly in the peripheral zone

Aggressiveness

Tend to be more aggressive

Detection

Often detected through biopsy or advanced imaging

Detection Challenges in the Peripheral Zone

Finding prostate cancer in the peripheral zone can be tough. This is because of where it is and the type of tumors it has. Tests like digital rectal exams and PSA tests help, but they’re not perfect.

New imaging methods, like MRI, help find tumors in this zone better. But, a biopsy is the best way to confirm a diagnosis.

It’s vital to catch prostate cancer early. Men should know the signs and symptoms. Regular check-ups and screenings can make a big difference for those with prostate cancer.

Other Zones Where Prostate Cancer Develops

Prostate cancer can start in the peripheral zone, but it can also begin in the transition and central zones. Knowing about these areas is key for finding and treating the cancer well.

Transition Zone Cancers (10-20% of Cases)

The transition zone is near the urethra. It’s where benign prostatic hyperplasia (BPH) often happens. Yet, about 10-20% of prostate cancers start here.

Cancers in this zone are different from those in the peripheral zone. They might have higher PSA levels. They can also be harder to find with just a digital rectal exam (DRE).

Central Zone Cancers (Rare Cases)

The central zone is where prostate cancer rarely starts. These cancers are often aggressive and might be found later because of their location.

It’s hard to find central zone cancers early. They’re not easy to feel during a DRE. They also might not cause symptoms until they grow a lot.

Differences in Growth Patterns by Zone

Prostate cancer grows differently in each zone. Cancers in the transition zone grow slower. Those in the central zone grow faster.

Knowing these differences helps us tailor treatments. We must look at where the cancer started to understand how aggressive it is. This helps us choose the best treatment for each patient.

Zone

Frequency of Cancer

Growth Pattern

Detection Challenges

Peripheral Zone

70-80%

Varies

Moderate

Transition Zone

10-20%

Often slower

Higher due to location

Central Zone

Rare

Often more aggressive

High due to deep location

By knowing how prostate cancer acts in different zones, we can do better at diagnosing and treating it. This leads to better results for patients.

Global Epidemiology of Prostate Cancer

Prostate cancer affects many people worldwide, with over 1.2 million new cases each year. It’s vital to understand this to fight the disease better.

1.2 Million New Cases Annually Worldwide

Prostate cancer is a big health problem, with many new cases every year. We need to spread awareness and screen more people.

Second Most Common Cancer in Men Globally

Prostate cancer is the second most common cancer in men globally. We must keep researching to find better treatments and improve survival rates.

Fifth Leading Cause of Male Cancer Death

Even with better treatments, prostate cancer is the fifth leading cause of death in men. Early detection and effective treatment are key to saving lives.

Regional Variations in Prostate Cancer Rates

Prostate cancer rates vary greatly around the world. This shows that genetics, environment, and lifestyle affect the disease’s development and spread.

Region

Incidence Rate

Mortality Rate

North America

High

Moderate

Europe

Moderate to High

Moderate

Asia

Low to Moderate

Low

Africa

Low

Low

Knowing these differences helps us create better screening and treatment plans for different areas.

Risk Factors for Developing Prostate Cancer

Knowing the risk factors for prostate cancer is key to catching it early. Prostate cancer, like many cancers, has certain risk factors. These factors can increase a man’s chance of getting the disease. We’ll look at these factors to help spot who’s at higher risk.

Age as the Primary Risk Factor

Age is the biggest risk factor for prostate cancer. The risk goes up a lot after 50. Most cases are found in men over 65. As we get older, our prostate cells are more likely to get genetic changes that lead to cancer.

12.9% Lifetime Risk in Men

About 1 in 8 men will get prostate cancer in their lifetime. This means a 12.9% chance. This number shows how important it is to be aware and get checked.

Genetic and Family History Considerations

A family history of prostate cancer is a big risk factor. Men with a first-degree relative (father or brother) diagnosed are at higher risk. Certain genetic mutations, like in BRCA1 and BRCA2, also raise the risk. But these are more linked to breast and ovarian cancer.

Racial and Ethnic Risk Variations

Prostate cancer rates differ by race and ethnicity. African American men face the highest rates and often get aggressive cancer younger. Asian and Hispanic men, on the other hand, have lower rates than non-Hispanic white men.

Key Risk Factors:

  • Age: Risk increases after 50.
  • Family History: Having a first-degree relative with prostate cancer.
  • Genetic Mutations: Specific mutations like BRCA1 and BRCA2.
  • Race/Ethnicity: Higher risk in African American men.

By knowing these risk factors, men can take steps to stay healthy. This includes regular check-ups and talking to their doctors about their risk.

How Prostate Cancer Progresses

It’s important to know how prostate cancer grows and spreads. This knowledge helps in managing and treating the disease. Prostate cancer goes through many stages, from the first cell changes to advanced disease.

From Normal Cells to Cancerous Growth

Prostate cancer starts with changes in normal cells. These changes cause cells to grow out of control, forming a tumor. Genetic mutations are key in this process. They can come from genes we inherit or from our environment.

Stages of Prostate Cancer Development

Prostate cancer goes through different stages:

  • Localized cancer, where the tumor stays in the prostate gland.
  • Locally advanced cancer, where the tumor spreads to nearby tissues.
  • Metastatic cancer, where the cancer spreads to distant parts of the body.

Knowing these stages helps doctors choose the best treatment.

Metastatic Pathways and Spread

When cancer cells break away, they can travel through the blood or lymph system. They can then form new tumors in other parts of the body. Common places for these new tumors include bones, lymph nodes, and organs like the lungs and liver.

Stage

Characteristics

Common Sites of Spread

Localized

Cancer confined to the prostate

None

Locally Advanced

Cancer spread to surrounding tissues

Surrounding tissues

Metastatic

Cancer spread to distant parts of the body

Bones, lymph nodes, lungs, liver

Knowing how prostate cancer spreads helps doctors find better treatments. This improves how well patients do.

Detecting Prostate Cancer: Screening and Diagnosis

Finding prostate cancer early can greatly improve treatment results and life expectancy. We use different methods to find prostate cancer, like screening tests and diagnostic procedures.

PSA Testing and Digital Rectal Examination

PSA testing is a blood test that checks for prostate-specific antigen levels. High levels might mean cancer, prostatitis, or an enlarged prostate. The digital rectal examination (DRE) is also key. It lets a doctor feel the prostate gland for any oddities.

PSA Testing: PSA testing isn’t a surefire way to find cancer. But it’s helpful in spotting men who might need more tests. A PSA level above 4.0 ng/mL usually means more checks are needed.

Advanced Imaging Techniques

Modern imaging, like multiparametric MRI, has changed how we find and understand prostate cancer. These methods give clear pictures of the prostate gland. They help spot areas that might need a biopsy.

Multiparametric MRI: This imaging combines different types of information. It’s great for finding serious prostate cancer. It also helps guide biopsies and check how far the cancer has spread.

Biopsy Procedures and Interpretation

A biopsy takes small tissue samples from the prostate gland for a microscope check. The Gleason score from these results shows how aggressive the cancer is.

Gleason Score

Cancer Aggressiveness

2-6

Low to moderate

7

Moderate to high

8-10

High

Why Early Detection Matters

Finding prostate cancer early is key. It lets doctors treat it before it spreads. This can greatly improve treatment success and survival chances.

Talking about screening with a doctor is very important. This is true for men with risk factors like family history or being African American.

Understanding Prostate Cancer Grading and Staging

Grading and staging are key to finding the right treatment for prostate cancer. Grading looks at how aggressive the cancer cells are. Staging checks how far the cancer has spread.

Gleason Score System

The Gleason score is a common way to grade prostate cancer. It looks at the cancer cells under a microscope. Scores range from 2 to 10, with higher numbers meaning more aggressive cancer.

We use the Gleason score to group prostate cancers by risk. For example, a score of 6 or less is low-risk. A score of 8 or higher is high-risk.

TNM Staging Classification

The TNM system helps us understand how far prostate cancer has spread. It looks at the tumor size (T), nearby lymph nodes (N), and if it has spread (M).

This system gives us a clear picture of the cancer’s spread. It helps us choose the best treatment.

Risk Stratification Approaches

Risk stratification groups prostate cancer patients by their cancer’s characteristics. This makes treatment plans more personal.

Risk Category

Gleason Score

PSA Level

Clinical Stage

Low Risk

6 or less

<10 ng/mL

T1-T2a

Intermediate Risk

7

10-20 ng/mL

T2b-T2c

High Risk

8 or higher

>20 ng/mL

T3-T4

Significance of 70% Localized Cases at Diagnosis

About 70% of prostate cancer cases are caught early, when the cancer is only in the prostate. This shows how important early detection and accurate staging are.

When caught early, treatments work better. This means patients have a better chance of a good outcome.

Treatment Options for Prostate Cancer

It’s important to know the different ways to treat prostate cancer. The right treatment depends on the cancer’s stage and grade, and the patient’s health.

Active Surveillance for Low-Risk Disease

Men with low-risk prostate cancer might choose active surveillance. This means watching the cancer closely with tests and biopsies, but not treating it right away. It aims to avoid treatment’s side effects while keeping an eye on the cancer.

Active surveillance is good for older men or those with other health problems. It helps avoid unnecessary treatments. But, it’s key to follow up regularly to catch any changes in the cancer.

Surgical Interventions: Radical Prostatectomy

Surgery is a common treatment for prostate cancer, mainly for localized disease. Radical prostatectomy removes the prostate gland. It can be done in different ways, like open surgery, laparoscopic surgery, or robot-assisted surgery.

The choice of surgery method depends on the surgeon’s skill and the patient’s condition. Robot-assisted surgery, for example, is more precise and might have fewer complications.

Surgical Technique

Advantages

Potential Complications

Open Surgery

Wide access, potentially easier for complex cases

Longer recovery time, higher risk of infection

Laparoscopic Surgery

Less invasive, quicker recovery

Steeper learning curve for surgeons, limited visibility

Robot-Assisted Surgery

High precision, less blood loss, quicker recovery

High cost, dependency on technology

Radiation Therapy Approaches

Radiation therapy is a good treatment for prostate cancer. It uses high-energy rays to kill cancer cells. There are two main types: external beam radiation therapy (EBRT) and brachytherapy.

EBRT sends radiation from outside the body and is used for more advanced cancers. Brachytherapy places radioactive seeds in the prostate. This delivers a high dose of radiation locally while protecting other tissues.

Radiation Oncologist

Hormone Therapy and Chemotherapy

Hormone therapy, or androgen deprivation therapy, treats prostate cancer by lowering male hormones. This slows cancer cell growth. It’s often used with other treatments or for advanced cancer.

Chemotherapy uses drugs to kill cancer cells. It’s mainly for prostate cancer that has spread. It’s often used with hormone therapy for better results.

Finding the right treatment can be tough. Our team is here to help. We provide care and support to help patients make informed choices about their treatment.

Localized vs. Advanced Prostate Cancer Management

It’s important to know the difference between localized and advanced prostate cancer. The treatment plan changes based on the cancer’s stage. We’ll look at these differences closely.

Approaches to Localized Disease

For localized prostate cancer, the main goal is to get rid of the cancer without harming your quality of life. Active surveillance is often suggested for low-risk patients. This means regular check-ups with PSA tests, digital rectal exams, and biopsies.

If treatment is needed, radical prostatectomy or radiation therapy are common choices. The right option depends on your health, the cancer’s details, and what you prefer.

Treatment for Advanced or Metastatic Disease

For advanced or metastatic prostate cancer, the focus is on controlling the disease and improving your quality of life. Hormone therapy is key, as it lowers testosterone levels that can help cancer grow.

Other treatments might include chemotherapy, targeted therapy, or joining clinical trials for new treatments. Palliative care is also important, focusing on easing symptoms and stress.

Decision-Making Factors for Treatment Selection

Choosing the right treatment for prostate cancer involves many factors. These include the cancer’s stage and grade, your overall health, and your personal wishes. Multidisciplinary teams of healthcare experts work together to make the best decisions.

Multidisciplinary Care Approaches

A team of specialists, like urologists and oncologists, work together in prostate cancer care. They create a treatment plan that fits the patient’s needs.

Aspect

Localized Prostate Cancer

Advanced Prostate Cancer

Treatment Goal

Eliminate the cancer

Control the disease, manage symptoms

Primary Treatments

Surgery, Radiation Therapy

Hormone Therapy, Chemotherapy

Role of Active Surveillance

Common for low-risk patients

Not applicable

Preventing Prostate Cancer: Current Evidence

There’s no surefire way to stop prostate cancer, but some lifestyle changes and medical steps can help. Looking into how to prevent prostate cancer, we find many ways to lower risk. These include different methods that can help an individual’s risk.

Dietary and Lifestyle Modifications

Diet and lifestyle are key in fighting prostate cancer. Eating lots of fruits, vegetables, and whole grains can help. Foods like tomatoes and fish, rich in antioxidants and omega-3s, also play a role.

  • Keep a healthy weight with a balanced diet and exercise.
  • Do at least 30 minutes of brisk walking a day.
  • Drink less processed meat and high-fat dairy.

Chemoprevention Strategies

Chemoprevention uses substances to stop cancer before it starts. Some supplements and drugs might help lower prostate cancer risk. For example, finasteride and dutasteride, used for BPH, are being studied for prevention.

Regular Screening Recommendations

Screening early is key to managing prostate cancer. PSA tests and DREs are advised for those at high risk or over 50. How often to screen depends on individual risk and doctor’s advice.

Risk Reduction Approaches

Other ways to reduce risk include avoiding toxins and managing stress. Men with a family history or other risk factorsshould get a personalized risk check. This helps tailor prevention plans.

By using diet, chemoprevention, screening, and risk reduction, we can fight prostate cancer. It’s vital to talk to doctors to create a prevention plan that fits you.

Living with Prostate Cancer: Quality of Life Considerations

Living with prostate cancer can be tough, but the right support makes a big difference. It affects physical health, emotional well-being, and social life. With the right care, patients can keep a good quality of life.

Managing Treatment Side Effects

Managing side effects is key to a good life. Common issues include urinary problems, erectile dysfunction, and feeling tired. We help patients find ways to lessen these effects, improving their overall health.

For example, pelvic floor therapy can help with bladder issues. Medications and lifestyle changes can tackle erectile dysfunction and fatigue. These steps help patients feel better overall.

Psychological and Emotional Support

Psychological and emotional support are critical for prostate cancer patients. Counseling and support groups offer a safe place to share and get support. It’s a chance to connect with others facing similar challenges.

We understand the emotional toll of prostate cancer. Our team provides emotional support and counseling. They help patients deal with their feelings and adjust to their new reality.

Long-term Survivorship Issues

Long-term survivorship issues are important as patients live longer. These include managing ongoing side effects, watching for cancer return, and dealing with the emotional impact of cancer history.

  • Regular check-ups are key for watching for cancer return and managing side effects.
  • Survivorship care plans help patients deal with life after treatment. They cover physical, emotional, and practical needs.

Support Resources for Patients and Families

Support resources are vital for prostate cancer patients and their families. These include educational materials, support groups, counseling, and online resources.

We offer a variety of support resources. They help patients and families face prostate cancer challenges. With these resources, patients can improve their quality of life and get the support they need.

“The care and support I received during my treatment for prostate cancer were exceptional. The team helped me manage side effects and provided emotional support when I needed it most.”

A prostate cancer survivor

Advancements in Prostate Cancer Care and Research

Recent years have seen big changes in prostate cancer care. These changes have made diagnosis and treatment better. New ways to fight this disease are being found, helping patients more.

Innovative Diagnostic Technologies

Diagnosing prostate cancer is now more accurate thanks to new technologies. Tools like multiparametric MRI help find cancer better. This lets doctors plan treatments that really work.

Key Diagnostic Advancements:

  • Multiparametric MRI for precise tumor localization
  • Advanced biopsy techniques for accurate diagnosis
  • Genomic testing for personalized risk assessment

A study demonstrates that the use of MRI has significantly improved the detection of serious prostate cancer cases. It means fewer unnecessary biopsies.

“The integration of advanced diagnostic technologies has revolutionized prostate cancer care, enabling healthcare providers to offer more precise and effective treatment options.”

Prostate Cancer Specialist

Emerging Treatment Approaches

New treatments for prostate cancer are giving patients hope. These include targeted therapies, immunotherapies, and new radiation methods. Liv Hospital is leading in using these new treatments.

Treatment Approach

Description

Benefits

Targeted Therapy

Precision medicine targeting specific cancer cells

Reduced side effects, improved efficacy

Immunotherapy

Stimulating the immune system to fight cancer

Enhanced immune response, long-term remission possible

Advanced Radiation

High-precision radiation therapy minimizing damage to healthy tissues

Improved tumor control, reduced toxicity

Liv Hospital’s Contribution to Prostate Cancer Care

Liv Hospital is dedicated to top-notch prostate cancer care. We use the latest in diagnosis and treatment. Our team works with patients to create the best treatment plans.

Future Directions in Prostate Cancer Management

Research is always finding new ways to manage prostate cancer. Future plans include more personal and precise treatments. New tech like AI will help make diagnosis and treatment even better.

We aim to be leaders in these advancements. This way, our patients get the best care possible.

Conclusion

Understanding prostate cancer is key in the fight against this health issue. We’ve looked at how it develops, how to detect it, and the treatments available. Early detection and new care methods are vital for better patient results.

It’s important to spread awareness about prostate cancer. This helps educate men and encourages them to look after their health. Knowing the risks, like age and family history, helps men make better health choices.

New treatments for prostate cancer have made a big difference. There are many options, like active surveillance, surgery, and radiation therapy. The right treatment depends on each person’s situation.

We need to keep researching and spreading awareness to fight prostate cancer worldwide. Together, we can find better treatments and support those dealing with this disease.

FAQ

Where does prostate cancer typically start?

Prostate cancer usually starts in the peripheral zone of the prostate gland.

What is the role of the prostate gland in male reproductive health?

The prostate gland makes prostatic fluid. This fluid is key for sperm health and is vital for male reproductive health.

What are the risk factors for developing prostate cancer?

Age is the main risk factor. Genetic and family history, racial, and ethnic variations also play a part.

How is prostate cancer detected?

Detection methods include PSA testing, digital rectal examination, advanced imaging, and biopsy procedures.

What is the Gleason score, and how is it used?

The Gleason score grades prostate cancer. It helps determine how aggressive the cancer is and guides treatment.

What are the treatment options for prostate cancer?

Treatment options include active surveillance, surgery, radiation therapy, hormone therapy, and chemotherapy.

How does the stage of prostate cancer impact treatment?

The stage and grade of prostate cancer, along with the patient’s health, affect treatment choices.

Can prostate cancer be prevented?

While prevention is not guaranteed, dietary and lifestyle changes, chemoprevention, and regular screening can lower risk.

What are the challenges in detecting prostate cancer in the peripheral zone?

Detecting tumors in the peripheral zone is challenging. This highlights the need for advanced diagnostic techniques.

How does prostate cancer progress?

Prostate cancer starts with normal cells turning into cancerous growth. It goes through various stages and can spread.

What is the significance of the peripheral zone in prostate cancer?

The peripheral zone is where most prostate cancer starts, making up 70-80% of cases.

How does Liv Hospital contribute to prostate cancer care?

Liv Hospital offers advanced care for prostate cancer patients. It uses the latest diagnostic and treatment technologies.

References:

National Center for Biotechnology Information. (2019). Epidemiology and risk factors of prostate cancer. PMC, 6497009. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497009

Trusted Worldwide
30
Years of
Experience
30 Years Badge

With patients from across the globe, we bring over three decades of medical

Prof. MD.  Adalet Demir Prof. MD. Adalet Demir TEMP. Cancer
Patient Reviews
Reviews from 9,651
4,9

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Op. MD. Enes Kara

Op. MD. Enes Kara

Spec. MD. Duygu Amine Garavi

Op. MD. Hatice Şahin Bıkmaz

Op. MD. Hatice Şahin Bıkmaz

DDS. Doğan Tanrıverdi

DDS. Doğan Tanrıverdi

Assoc. Prof. MD. Ozan Balakan

Assoc. Prof. MD. Ozan Balakan

Op. MD. Sami Şahin

Op. MD. Sami Şahin

Op. Md. İdris Kıvanç Cavıldak

Op. Md. İdris Kıvanç Cavıldak

MD. RİFAH HEMİDOV

MD. RİFAH HEMİDOV

Assoc. Prof. MD. Emrah Dilaver

Assoc. Prof. MD. Emrah Dilaver

Prof. MD. Mehmet Tahir Ünal

Prof. MD. Mehmet Tahir Ünal

Op. MD. Yaman Khoraki

Op. MD. Yaman Khoraki

Spec. MD. Fikret Gören

Spec. MD. Fikret Gören

Your Comparison List (you must select at least 2 packages)